Clinical Trial Update: Intratympanic Steroid for Bell's Palsy [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial evaluating intratympanic dexamethasone for Bell's palsy has completed, with results posted in November 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bell Palsy
• Facial Nerve Palsy

Drugs mentioned

• Dexamethasone (intratympanic) (dexamethasone)

Snippet

Sponsor: University of Missouri-Columbia | Conditions: Bell's Palsy, Facial Nerve Paresis | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2024-11-05